Relief Therapeutics is Biotechnology in Switzerland that focus on Therapeutics Holding AG business. Founded in 2013. They cover business area such as Relief Therapeutics Holding AG, clinical stage project, drug, natural human origin, its operation, diabetic complication, respiratory disease, Aviptadil, Atexakin, alfa, immune regulatory activity, function, diverse tissue, organ, Switzerland.
2013
( 11 years old in 2024 )
Therapeutics Holding AG
-
Fondation EIP, Batiment F2/F3
Avenue de Sécheron 15
1202 Geneva
Switzerland
Private
Relief Therapeutics Holding AGclinical stage projectdrugnatural human originits operationdiabetic complicationrespiratory diseaseAviptadilAtexakinalfaimmune regulatory activityfunctiondiverse tissueorganSwitzerland
* We use standard office opening hours in near Relief Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Relief Therapeutics is Biotechnology business from Switzerland that founded in 2013 (11 years old in 2024), Relief Therapeutics business is focusing on Therapeutics Holding AG.
Relief Therapeutics headquarter office and corporate office address is located in Fondation EIP, Batiment F2/F3 Avenue de Sécheron 15 1202 Geneva Switzerland.
Relief Therapeutics was founded in Switzerland.
In 2024, Relief Therapeutics is currently focus on Therapeutics Holding AG sector.
Above is snippet of Google Trends for "Therapeutics Holding AG" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Relief Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
